Isaacs JT - Search Results

1

Targeting the fibroblast growth factor pathway in molecular subtypes of castration-resistant prostate cancer.

Labrecque MP, Brown LG, Coleman IM, Nguyen HM, Dalrymple S, Brennen WN, Isaacs JT, Li D, Lakely B, DeLucia DC, Lee JK, Schweizer MT, Lin DW, Corey E, Nelson PS, Morrissey C. Labrecque MP, et al. Among authors: isaacs jt. Prostate. 2024 Jan;84(1):100-110. doi: 10.1002/pros.24630. Epub 2023 Oct 5. Prostate. 2024. PMID: 37796107 Free PMC article.

2

Response of rat and human prostatic cancers to the novel 5 alpha-reductase inhibitor, SK&F 105657.

Lamb JC, Levy MA, Johnson RK, Isaacs JT. Lamb JC, et al. Among authors: isaacs jt. Prostate. 1992;21(1):15-34. doi: 10.1002/pros.2990210103. Prostate. 1992. PMID: 1641369

3

Epidemiologic evidence regarding predisposing factors to prostate cancer.

Carter BS, Carter HB, Isaacs JT. Carter BS, et al. Among authors: isaacs jt. Prostate. 1990;16(3):187-97. doi: 10.1002/pros.2990160302. Prostate. 1990. PMID: 1691839 Review.

4

H-ras expression, genetic instability, and acquisition of metastatic ability by rat prostatic cancer cells following v-H-ras oncogene transfection.

Ichikawa T, Schalken JA, Ichikawa Y, Steinberg GD, Isaacs JT. Ichikawa T, et al. Among authors: isaacs jt. Prostate. 1991;18(2):163-72. doi: 10.1002/pros.2990180209. Prostate. 1991. PMID: 2006121

5

Differential effects of growth factor antagonists on neoplastic and normal prostatic cells.

Morton RA, Isaacs JT, Isaacs WB. Morton RA, et al. Among authors: isaacs wb, isaacs jt. Prostate. 1990;17(4):327-36. doi: 10.1002/pros.2990170408. Prostate. 1990. PMID: 2251224

6

Activation of a Ca2+-Mg2+-dependent endonuclease as an early event in castration-induced prostatic cell death.

Kyprianou N, English HF, Isaacs JT. Kyprianou N, et al. Among authors: isaacs jt. Prostate. 1988;13(2):103-17. doi: 10.1002/pros.2990130203. Prostate. 1988. PMID: 2845374

7

Nonrandom involvement of chromosome 4 in the progression of rat prostatic cancer.

Isaacs JT, Hukku B. Isaacs JT, et al. Prostate. 1988;13(2):165-88. doi: 10.1002/pros.2990130208. Prostate. 1988. PMID: 3174494

8

Inhibition of tumor angiogenesis and the therapeutic ability of linomide against rat prostatic cancers.

Vukanovic J, Hartley-Asp B, Isaacs JT. Vukanovic J, et al. Among authors: isaacs jt. Prostate. 1995 May;26(5):235-46. doi: 10.1002/pros.2990260503. Prostate. 1995. PMID: 7538663

9

Molecular and cellular changes associated with the acquisition of metastatic ability by prostatic cancer cells.

Rinker-Schaeffer CW, Partin AW, Isaacs WB, Coffey DS, Isaacs JT. Rinker-Schaeffer CW, et al. Among authors: isaacs wb, isaacs jt. Prostate. 1994 Nov;25(5):249-65. doi: 10.1002/pros.2990250505. Prostate. 1994. PMID: 7971516 Review.

10

Proliferation-dependent vs. independent programmed cell death of prostatic cancer cells involves distinct gene regulation.

Furuya Y, Isaacs JT. Furuya Y, et al. Among authors: isaacs jt. Prostate. 1994 Dec;25(6):301-9. doi: 10.1002/pros.2990250604. Prostate. 1994. PMID: 7997434

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

372 results

Search Page

Filters